{
  "main_header": {
    "sid": 338998,
    "name": "Gufic BioScience",
    "stock_name": "Gufic BioScience",
    "full_name": "Gufic BioSciences Ltd",
    "name_url": "stocks-analysis/gufic-bioscience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "322.15",
    "chg": 8.85,
    "chgp": "2.82%",
    "dir": 1,
    "prev_price": "313.30",
    "mcapval": "3,230.44 Cr",
    "mcap": "Small Cap",
    "scripcode": 509079,
    "symbol": "GUFICBIO",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE742B01025",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:19 AM",
    "bse_nse_vol": "26.3 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Gufic BioSciences Faces Technical Shift Amid Declining Profits and Rising Interest Expenses",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-stock-downgraded-to-strong-sell-amid-deteriorating-financial-indicators-1572859",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GuficBioScience_mojoScore_770831.png",
        "date": "2025-03-24 08:01:00",
        "description": "Gufic BioSciences has experienced a recent evaluation adjustment, indicating a shift in its technical outlook. Key metrics suggest potential challenges, with a decline in profits over the past year. Despite this, institutional investor participation has slightly increased, reflecting ongoing interest in the company's long-term potential."
      },
      {
        "title": "Gufic BioSciences Faces Technical Trend Shifts Amid Market Fluctuations and Performance Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-technical-trend-shifts-from-sideways-to-bearish-amid-stock-price-decline-1572742",
        "imagepath": "",
        "date": "2025-03-24 08:00:35",
        "description": "Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 341.75, slightly down from the previous close of 345.35. Over the past year, Gufic BioSciences has shown a return of 15.93%, outperforming the Sensex, which recorded a return of 5.87% in the same period. However, the year-to-date performance indicates a decline of 24.57%, contrasting with the Sensex's modest drop of 1.58%.\n\nIn terms of technical indicators, the weekly MACD and KST are signaling bearish trends, while the monthly metrics show a mildly bearish outlook. The Bollinger Bands also reflect a similar sentiment, indicating a cautious market environment. Despite these trends, the On-Balance Volume (OBV) remains mildly bullish on both weekly and monthly scales, suggesting some underlying strength.\n\nGufic BioSc..."
      },
      {
        "title": "Gufic BioSciences Shows Strong Long-Term Growth Amid Recent Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-reports-15-93-annual-growth-outperforming-sensexs-5-87-gain-1559487",
        "imagepath": "",
        "date": "2025-03-21 18:00:19",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has seen notable stock activity today. The company, with a market capitalization of Rs 3,480.00 crore, currently holds a price-to-earnings (P/E) ratio of 41.79, which is above the industry average of 37.36.\n\nIn terms of performance, Gufic BioSciences has delivered a 15.93% return over the past year, significantly outperforming the Sensex, which has gained 5.87% during the same period. However, the stock has faced challenges recently, with a decline of 1.04% today, contrasting with the Sensex's increase of 0.73%. Over the past month, Gufic BioSciences has experienced a notable drop of 10.90%, while the Sensex has risen by 2.12%.\n\nLooking at longer-term trends, Gufic BioSciences has shown impressive growth, with a staggering 682.93% increase over the past five years, compared to the Sensex's 157.07%. Despite recent volatility, ..."
      },
      {
        "title": "Gufic BioSciences Shows Mixed Technical Indicators Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-price-increase-4-1462526",
        "imagepath": "",
        "date": "2025-03-19 08:01:15",
        "description": "Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 335.25, showing a slight increase from the previous close of 327.90. Over the past year, Gufic BioSciences has demonstrated a return of 12.42%, outperforming the Sensex, which recorded a return of 3.51% during the same period.\n\nIn terms of technical indicators, the company exhibits a mixed performance. The MACD shows bearish tendencies on both weekly and monthly charts, while the RSI indicates no significant signals. Bollinger Bands and KST also reflect a mildly bearish outlook, although moving averages on a daily basis suggest a mildly bullish trend. The On-Balance Volume (OBV) indicates a bullish stance on a monthly basis, while the weekly trend shows no clear direction.\n\nNotably, Gufic BioSciences has shown rema..."
      },
      {
        "title": "Gufic BioSciences Faces Mixed Technical Trends Amid Market Volatility and Performance Variability",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-stock-price-decline-1516345",
        "imagepath": "",
        "date": "2025-03-11 08:01:14",
        "description": "Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 350.25, down from a previous close of 364.75, with a notable 52-week high of 501.10 and a low of 278.00. Today's trading saw a high of 379.95 and a low of 350.00, indicating some volatility.\n\nThe technical summary reveals a mixed picture, with the MACD indicating bearish trends on both weekly and monthly scales. The Relative Strength Index (RSI) shows no significant signals, while Bollinger Bands reflect a bearish stance weekly and a sideways trend monthly. Moving averages present a mildly bullish outlook on a daily basis, contrasting with the bearish signals from the KST and Dow Theory metrics.\n\nIn terms of performance, Gufic BioSciences has shown varied returns compared to the Sensex. Over the past week, the stoc..."
      },
      {
        "title": "Gufic BioSciences Faces Mixed Technical Trends Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-price-increase-1228969",
        "imagepath": "",
        "date": "2025-03-07 08:01:29",
        "description": "Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 362.70, showing a notable increase from the previous close of 344.15. Over the past year, Gufic BioSciences has demonstrated resilience, with a return of 20.68%, significantly outperforming the Sensex, which recorded a modest gain of 0.34%.\n\nIn terms of technical indicators, the company presents a mixed picture. The MACD signals a bearish trend on a weekly basis, while the monthly outlook is mildly bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly periods. Bollinger Bands indicate a mildly bearish trend weekly, contrasting with a bullish stance monthly. Daily moving averages suggest a mildly bullish sentiment, while the On-Balance Volume (OBV) reflects a bullish tre..."
      },
      {
        "title": "Gufic BioSciences Opens Strong with 6.03% Gain Amid Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-stock-opens-with-6-03-gain-outperforming-sector-by-4-56-3-1217289",
        "imagepath": "",
        "date": "2025-03-06 10:35:04",
        "description": "Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has shown significant activity today, opening with a gain of 6.03%. The stock has outperformed its sector by 4.56%, marking a notable performance amidst broader market trends. Over the past three days, Gufic BioSciences has recorded a cumulative return of 10.26%, indicating a positive short-term trajectory.\n\nToday, the stock reached an intraday high of Rs 364.9, reflecting strong trading momentum. However, it is important to note that while the stock is currently above its 5-day moving averages, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting mixed signals in the longer-term trend.\n\nIn terms of performance metrics, Gufic BioSciences has experienced a decline of 14.52% over the past month, compared to a 5.50% drop in the Sensex. Technical indicators present a bearish outlook on a weekly basis, w..."
      },
      {
        "title": "Gufic BioSciences Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-5-1170659",
        "imagepath": "",
        "date": "2025-03-03 08:01:13",
        "description": "Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 330.00, down from a previous close of 336.00, with a 52-week high of 501.10 and a low of 278.00. Today's trading saw a high of 335.90 and a low of 320.85.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis, while the monthly perspective remains bullish. The Relative Strength Index (RSI) presents no signals for both weekly and monthly evaluations. Bollinger Bands and Dow Theory reflect a bearish sentiment on both weekly and monthly scales. Moving averages indicate a mildly bullish trend on a daily basis, while the KST shows a similar divergence between weekly and monthly evaluations.\n\nIn terms of returns, Gufic BioSciences has faced..."
      },
      {
        "title": "Gufic BioSciences Shows Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-3-1163376",
        "imagepath": "",
        "date": "2025-03-02 08:01:11",
        "description": "Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 330.00, down from a previous close of 336.00, with a 52-week high of 501.10 and a low of 278.00. Today's trading saw a high of 335.90 and a low of 320.85.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis while remaining bullish monthly. The Relative Strength Index (RSI) presents no signals for both weekly and monthly assessments. Bollinger Bands and Dow Theory reflect a bearish stance on a weekly basis, while moving averages indicate a mildly bullish trend daily. \n\nIn terms of returns, Gufic BioSciences has faced challenges compared to the Sensex. Over the past week, the stock has returned -13.96%, while the Sensex saw a declin..."
      }
    ],
    "total": 80,
    "sid": "338998",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/gufic-biosciences-338998"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2025",
      "details": "Intimation of Closure of Trading Window is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "19-Mar-2025",
      "details": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "21-Feb-2025",
      "details": "Written Transcript of Earnings Conference Call is attached herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gufic BioSciences Ltd has declared <strong>10%</strong> dividend, ex-date: 17 Sep 24",
          "dt": "2024-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gufic BioSciences Faces Technical Shift Amid Declining Profits and Rising Interest Expenses

2025-03-24 08:01:00

Gufic BioSciences has experienced a recent evaluation adjustment, indicating a shift in its technical outlook. Key metrics suggest potential challenges, with a decline in profits over the past year. Despite this, institutional investor participation has slightly increased, reflecting ongoing interest in the company's long-term potential.

Read More

Gufic BioSciences Faces Technical Trend Shifts Amid Market Fluctuations and Performance Challenges

2025-03-24 08:00:35

Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 341.75, slightly down from the previous close of 345.35. Over the past year, Gufic BioSciences has shown a return of 15.93%, outperforming the Sensex, which recorded a return of 5.87% in the same period. However, the year-to-date performance indicates a decline of 24.57%, contrasting with the Sensex's modest drop of 1.58%. In terms of technical indicators, the weekly MACD and KST are signaling bearish trends, while the monthly metrics show a mildly bearish outlook. The Bollinger Bands also reflect a similar sentiment, indicating a cautious market environment. Despite these trends, the On-Balance Volume (OBV) remains mildly bullish on both weekly and monthly scales, suggesting some underlying strength. Gufic BioSc...

Read More

Gufic BioSciences Shows Strong Long-Term Growth Amid Recent Volatility

2025-03-21 18:00:19

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has seen notable stock activity today. The company, with a market capitalization of Rs 3,480.00 crore, currently holds a price-to-earnings (P/E) ratio of 41.79, which is above the industry average of 37.36. In terms of performance, Gufic BioSciences has delivered a 15.93% return over the past year, significantly outperforming the Sensex, which has gained 5.87% during the same period. However, the stock has faced challenges recently, with a decline of 1.04% today, contrasting with the Sensex's increase of 0.73%. Over the past month, Gufic BioSciences has experienced a notable drop of 10.90%, while the Sensex has risen by 2.12%. Looking at longer-term trends, Gufic BioSciences has shown impressive growth, with a staggering 682.93% increase over the past five years, compared to the Sensex's 157.07%. Despite recent volatility, ...

Read More

Gufic BioSciences Shows Mixed Technical Indicators Amid Strong Long-Term Performance

2025-03-19 08:01:15

Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 335.25, showing a slight increase from the previous close of 327.90. Over the past year, Gufic BioSciences has demonstrated a return of 12.42%, outperforming the Sensex, which recorded a return of 3.51% during the same period. In terms of technical indicators, the company exhibits a mixed performance. The MACD shows bearish tendencies on both weekly and monthly charts, while the RSI indicates no significant signals. Bollinger Bands and KST also reflect a mildly bearish outlook, although moving averages on a daily basis suggest a mildly bullish trend. The On-Balance Volume (OBV) indicates a bullish stance on a monthly basis, while the weekly trend shows no clear direction. Notably, Gufic BioSciences has shown rema...

Read More

Gufic BioSciences Faces Mixed Technical Trends Amid Market Volatility and Performance Variability

2025-03-11 08:01:14

Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 350.25, down from a previous close of 364.75, with a notable 52-week high of 501.10 and a low of 278.00. Today's trading saw a high of 379.95 and a low of 350.00, indicating some volatility. The technical summary reveals a mixed picture, with the MACD indicating bearish trends on both weekly and monthly scales. The Relative Strength Index (RSI) shows no significant signals, while Bollinger Bands reflect a bearish stance weekly and a sideways trend monthly. Moving averages present a mildly bullish outlook on a daily basis, contrasting with the bearish signals from the KST and Dow Theory metrics. In terms of performance, Gufic BioSciences has shown varied returns compared to the Sensex. Over the past week, the stoc...

Read More

Gufic BioSciences Faces Mixed Technical Trends Amid Strong Long-Term Performance

2025-03-07 08:01:29

Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 362.70, showing a notable increase from the previous close of 344.15. Over the past year, Gufic BioSciences has demonstrated resilience, with a return of 20.68%, significantly outperforming the Sensex, which recorded a modest gain of 0.34%. In terms of technical indicators, the company presents a mixed picture. The MACD signals a bearish trend on a weekly basis, while the monthly outlook is mildly bearish. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly periods. Bollinger Bands indicate a mildly bearish trend weekly, contrasting with a bullish stance monthly. Daily moving averages suggest a mildly bullish sentiment, while the On-Balance Volume (OBV) reflects a bullish tre...

Read More

Gufic BioSciences Opens Strong with 6.03% Gain Amid Market Trends

2025-03-06 10:35:04

Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has shown significant activity today, opening with a gain of 6.03%. The stock has outperformed its sector by 4.56%, marking a notable performance amidst broader market trends. Over the past three days, Gufic BioSciences has recorded a cumulative return of 10.26%, indicating a positive short-term trajectory. Today, the stock reached an intraday high of Rs 364.9, reflecting strong trading momentum. However, it is important to note that while the stock is currently above its 5-day moving averages, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting mixed signals in the longer-term trend. In terms of performance metrics, Gufic BioSciences has experienced a decline of 14.52% over the past month, compared to a 5.50% drop in the Sensex. Technical indicators present a bearish outlook on a weekly basis, w...

Read More

Gufic BioSciences Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-03-03 08:01:13

Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 330.00, down from a previous close of 336.00, with a 52-week high of 501.10 and a low of 278.00. Today's trading saw a high of 335.90 and a low of 320.85. The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis, while the monthly perspective remains bullish. The Relative Strength Index (RSI) presents no signals for both weekly and monthly evaluations. Bollinger Bands and Dow Theory reflect a bearish sentiment on both weekly and monthly scales. Moving averages indicate a mildly bullish trend on a daily basis, while the KST shows a similar divergence between weekly and monthly evaluations. In terms of returns, Gufic BioSciences has faced...

Read More

Gufic BioSciences Shows Mixed Technical Trends Amid Market Evaluation Revision

2025-03-02 08:01:11

Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 330.00, down from a previous close of 336.00, with a 52-week high of 501.10 and a low of 278.00. Today's trading saw a high of 335.90 and a low of 320.85. The technical summary indicates a mixed performance across various indicators. The MACD shows a mildly bearish trend on a weekly basis while remaining bullish monthly. The Relative Strength Index (RSI) presents no signals for both weekly and monthly assessments. Bollinger Bands and Dow Theory reflect a bearish stance on a weekly basis, while moving averages indicate a mildly bullish trend daily. In terms of returns, Gufic BioSciences has faced challenges compared to the Sensex. Over the past week, the stock has returned -13.96%, while the Sensex saw a declin...

Read More

View All News